Merih Özbayburtlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Merih Özbayburtlu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- İbRahim Cagri Kaya
Eskişehir City Health Practice and Research Centers, University of Health Sciences, Department of Cardiovascular Surgery, Eskişehir, Türkiye
4 shared publications - Halil Ibrahim Bulut
Istanbul University Cerrahpasa, Istanbul, Turkey
3 shared publications - Alper Selim Kocaoğlu
Department of Cardiovascular Surgery, Eskisehir City Hospital, Eskisehir, Turkey
2 shared publications - Hüseyin Gemalmaz
Prof. Dr. Cemal Taşçıoğlu Şehir Hastanesi, Kalp ve Damar Cerrahisi Kliniği, İstanbul, Türkiye
2 shared publications - Ozan Onur Balkanay
Department of Cardiovascular Surgery, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
2 shared publications - Yıldırım Gülteki̇n
Kırıkkale Üniversitesi Tıp Fakültesi
2 shared publications
Latest Publications
- 31 May 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
THE IMPACT OF CHEST TUBE PLACEMENT TECHNIQUES ON ATRIAL FIBRILLATION DURING CORONARY BYPASS SURGERY
Introduction: Postoperative atrial fibrillation (POAF) is a common complication after coronary artery bypass grafting (CABG), with incidence rates reported between 20% and 40%. Pain and hypoxia related to intercostal chest tube placement may play a role in the development of POAF. This study sought to compare the impacts of midaxillary intercostal versus subxiphoid chest tube placement on the development of postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass. Methods: A retrospective, single-center study was performed involving 675 patients who underwent isolated coronary artery bypass grafting (CABG) utilizing the left internal mammary artery (LIMA) from January 2021 to March 2025. Patients were categorized into two groups: Group 1 (n=442) underwent midaxillary intercostal drainage, while Group 2 (n=233) received subxiphoid drainage. The two groups were similar in terms of demographic and perioperative factors. The primary outcome was the occurrence of POAF; secondary outcomes encompassed postoperative pain scores, oxygenation metrics, and drainage efficacy. Results: POAF manifested in 34.2% of Group 1 and 18% of Group 2 (p<0.05). Subxiphoid drainage was correlated with elevated postoperative arterial pO₂ (82 vs. 74 mmHg; p=0.042), reduced pCO₂ (38 vs. 42 mmHg; p=0.025), and diminished pain scores (VAS 5 vs. 8; p=0.002). Group 2 also used a lot less pain medicine. There was no significant difference in the effectiveness of drainage or the rates of pleural effusion. Conclusion: Subxiphoid chest tube placement following CABG is linked to diminished pain, enhanced oxygenation, and markedly lower rates of postoperative atrial fibrillation (POAF) in comparison to intercostal placement. This method is a simple, flexible way to improve postoperative results, and it should be included in CABG surgical protocols.
- 31 May 2026
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
THE IMPACT OF CHEST TUBE PLACEMENT TECHNIQUES ON ATRIAL FIBRILLATION DURING CORONARY BYPASS SURGERY
Introduction: Postoperative atrial fibrillation (POAF) is a common complication after coronary artery bypass grafting (CABG), with incidence rates reported between 20% and 40%. Pain and hypoxia related to intercostal chest tube placement may play a role in the development of POAF. This study sought to compare the impacts of midaxillary intercostal versus subxiphoid chest tube placement on the development of postoperative atrial fibrillation (POAF) in patients undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass. Methods: A retrospective, single-center study was performed involving 675 patients who underwent isolated coronary artery bypass grafting (CABG) utilizing the left internal mammary artery (LIMA) from January 2021 to March 2025. Patients were categorized into two groups: Group 1 (n=442) underwent midaxillary intercostal drainage, while Group 2 (n=233) received subxiphoid drainage. The two groups were similar in terms of demographic and perioperative factors. The primary outcome was the occurrence of POAF; secondary outcomes encompassed postoperative pain scores, oxygenation metrics, and drainage efficacy. Results: POAF manifested in 34.2% of Group 1 and 18% of Group 2 (p<0.05). Subxiphoid drainage was correlated with elevated postoperative arterial pO₂ (82 vs. 74 mmHg; p=0.042), reduced pCO₂ (38 vs. 42 mmHg; p=0.025), and diminished pain scores (VAS 5 vs. 8; p=0.002). Group 2 also used a lot less pain medicine. There was no significant difference in the effectiveness of drainage or the rates of pleural effusion. Conclusion: Subxiphoid chest tube placement following CABG is linked to diminished pain, enhanced oxygenation, and markedly lower rates of postoperative atrial fibrillation (POAF) in comparison to intercostal placement. This method is a simple, flexible way to improve postoperative results, and it should be included in CABG surgical protocols.
- Open Access
- 29 July 2024
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
- Vol. 5 (2) , 53-59
THE EFFECT OF POSTOPERATIVE ADMINISTRATION OF LOWMOLECULAR- WEIGHT-HEPARIN (TINZAPARIN) ON ARTERIAL THROMBOSIS IN AN EXPERIMENTAL RAT MODEL
ÖZET Giriş: Düşük molekül ağırlıklı heparinler, venöz tromboembolizmin profilaksisinde ruhsatlıdır ancak arteriyel trombozun profilaksisinde yoktur. Bu çalışmada sıçan modelinde postoperatif düşük molekül ağırlıklı heparin tinzaparinin uygulanmasının arteriyel tromboz oranına etkisinin değerlendirilmesi amaçlandı. Yöntemler: On altı erkek Wistar Albino sıçanın sağ femoral arterleri transvers olarak kesildi ve daha sonra sürekli dikişle onarıldı. Sekiz sıçana ameliyat sonrası üç gün boyunca 175 IU/kg/gün tinzaparin verilirken, geri kalan sekiz sıçana tinzaparin verilmedi. Tüm sıçanlar ameliyat sonrası dördüncü günde tekrar ameliyata alınana kadar damar dolaşımı, kanama ve hematom açısından günlük olarak kontrol edildi. Vasküler açıklığı araştırmak ve histopatolojik inceleme için onarılan femoral arterden bir vasküler doku örneğini çıkarmak için yeniden ameliyat yapıldı. Tinzaparinin etkinliğini göstermek amacıyla anti-faktör Xa aktivitesinin saptanması için de bir kan örneği alındı. Bulgular: Postoperatif üç günlük takipte tinzaparin uygulanan sıçanların hiçbirinde damar dolaşım bozukluğu saptanmazken, tinzaparin tedavisi uygulanmayan iki sıçanda (%25) damar dolaşım bozukluğu tespit edildi. Her iki gruptaki sıçanların hiçbirinde cerrahi bölgede kanama veya hematom gelişmedi. Postoperatif dönemde tinzaparin uygulanan sıçanlarda anti-faktör Xa aktivitesinin, tinzaparin uygulanmayan sıçanlara göre anlamlı derecede yüksek olduğu görüldü (p<0,001). Histopatolojik incelemede tinzaparin tedavisi gören yalnızca bir sıçanda (%12,5) ve tinzaparin tedavisi uygulanmayan yedi sıçanda (%87,5) femoral arter insizyon hattında trombüs ve fibrin oluşumu saptandı (p˂0,001). Hiçbir grupta intimal hiperplazi saptanmadı ancak her iki grupta da karışık tipte inflamatuar hücre infiltrasyonu ve sütür çevresinde endotelyal ve fibroblastik aktivite dikkat çekti. Sonuç: Sıçan modelinde postoperatif subkutan 175 IU/kg/gün tinzaparin uygulamasının arteriyel cerrahi girişimlerde arteriyel tromboz oranını etkili bir şekilde azalttığı görüldü. Anahtar Kelimeler: Arteriyel tromboz, düşük molekül ağırlıklı heparin, tinzaparin
- 29 July 2024
- Published by Eskisehir Medical Journal, Eskisehir City Hospital in Eskisehir Medical Journal, Eskisehir City Hospital
- Vol. 5 (2) , 53-59
Open AccessTHE EFFECT OF POSTOPERATIVE ADMINISTRATION OF LOWMOLECULAR- WEIGHT-HEPARIN (TINZAPARIN) ON ARTERIAL THROMBOSIS IN AN EXPERIMENTAL RAT MODEL
ÖZET Giriş: Düşük molekül ağırlıklı heparinler, venöz tromboembolizmin profilaksisinde ruhsatlıdır ancak arteriyel trombozun profilaksisinde yoktur. Bu çalışmada sıçan modelinde postoperatif düşük molekül ağırlıklı heparin tinzaparinin uygulanmasının arteriyel tromboz oranına etkisinin değerlendirilmesi amaçlandı. Yöntemler: On altı erkek Wistar Albino sıçanın sağ femoral arterleri transvers olarak kesildi ve daha sonra sürekli dikişle onarıldı. Sekiz sıçana ameliyat sonrası üç gün boyunca 175 IU/kg/gün tinzaparin verilirken, geri kalan sekiz sıçana tinzaparin verilmedi. Tüm sıçanlar ameliyat sonrası dördüncü günde tekrar ameliyata alınana kadar damar dolaşımı, kanama ve hematom açısından günlük olarak kontrol edildi. Vasküler açıklığı araştırmak ve histopatolojik inceleme için onarılan femoral arterden bir vasküler doku örneğini çıkarmak için yeniden ameliyat yapıldı. Tinzaparinin etkinliğini göstermek amacıyla anti-faktör Xa aktivitesinin saptanması için de bir kan örneği alındı. Bulgular: Postoperatif üç günlük takipte tinzaparin uygulanan sıçanların hiçbirinde damar dolaşım bozukluğu saptanmazken, tinzaparin tedavisi uygulanmayan iki sıçanda (%25) damar dolaşım bozukluğu tespit edildi. Her iki gruptaki sıçanların hiçbirinde cerrahi bölgede kanama veya hematom gelişmedi. Postoperatif dönemde tinzaparin uygulanan sıçanlarda anti-faktör Xa aktivitesinin, tinzaparin uygulanmayan sıçanlara göre anlamlı derecede yüksek olduğu görüldü (p<0,001). Histopatolojik incelemede tinzaparin tedavisi gören yalnızca bir sıçanda (%12,5) ve tinzaparin tedavisi uygulanmayan yedi sıçanda (%87,5) femoral arter insizyon hattında trombüs ve fibrin oluşumu saptandı (p˂0,001). Hiçbir grupta intimal hiperplazi saptanmadı ancak her iki grupta da karışık tipte inflamatuar hücre infiltrasyonu ve sütür çevresinde endotelyal ve fibroblastik aktivite dikkat çekti. Sonuç: Sıçan modelinde postoperatif subkutan 175 IU/kg/gün tinzaparin uygulamasının arteriyel cerrahi girişimlerde arteriyel tromboz oranını etkili bir şekilde azalttığı görüldü. Anahtar Kelimeler: Arteriyel tromboz, düşük molekül ağırlıklı heparin, tinzaparin
- Open Access
- 8 September 2023
- Published by Galenos Yayinevi in International Journal of the Cardiovascular Academy
- Vol. 9 (3) , 60-65
Endovascular Revascularization of Lower Extremity Arteries: A Single-center Retrospective Report on Long Lesions (>100 mm)
- 8 September 2023
- Published by Galenos Yayinevi in International Journal of the Cardiovascular Academy
- Vol. 9 (3) , 60-65
Open AccessEndovascular Revascularization of Lower Extremity Arteries: A Single-center Retrospective Report on Long Lesions (>100 mm)
- Open Access
- 10 July 2023
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 26 (2) , 83-87
Preoperative Atrial Fibrillation and Coronary Artery Bypass Grafting Outcomes
Introduction: Traditionally, atrial fibrillation is considered a comorbid factor for coronary artery bypass surgery as well as other surgeries, however, current literature is still limited. In this study, the effects of preoperative atrial fibrillation on coronary artery bypass grafting were investigated. Patients and Methods: Following the hospital’s clinical trials ethics committee approval, data from 151 patients who underwent isolated coronary artery bypass surgery were collected with the assistance of the hospital’s electronic records system. The follow-up duration was 12 months. Statistically significant P value cut-off taken as 0.05. Results: The mean age was 61.5 and 26.6% (n= 40) of the patients were female. Preoperative atrial fibrillation (Afib) prevalence was 13.3% (n= 20). No significant differences were observed in patient demographics, metabolic, systemic, and cardiovascular conditions between the group with preoperative atrial fibrillation and the control group (p> 0.05). However, the previous myocardial infarction rate was found higher (38.9 vs. 70.0, p= 0.009), and carotid artery stenosis disease prevalence was found lower (18.2 vs. 0.0, p= 0.038), also mean glomerular filtration rate (GFR) was found lower (85.9 vs. 69.7, p= 0.002) in the patients with Afib. Intraoperative parameters were not statistically different among the group (p> 0.05). Despite the preoperative dysthymia history, myocardial infarction prevalence, and poor kidney function; there was no difference in terms of postoperative acute kidney injury rates, stroke rates, perioperative complication rates, and thirty-day and 12-month survival (p> 0.05). However, the re-revascularization requirement was higher in patients in the Afib group. Conclusion: Atrial fibrillation is a prevalent comorbidity in coronary artery bypass grafting patients. However, it was not found as a factor that related to mortality or morbidity and coronary surgery seems feasible in this patient group.
- 10 July 2023
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 26 (2) , 83-87
Open AccessPreoperative Atrial Fibrillation and Coronary Artery Bypass Grafting Outcomes
Introduction: Traditionally, atrial fibrillation is considered a comorbid factor for coronary artery bypass surgery as well as other surgeries, however, current literature is still limited. In this study, the effects of preoperative atrial fibrillation on coronary artery bypass grafting were investigated. Patients and Methods: Following the hospital’s clinical trials ethics committee approval, data from 151 patients who underwent isolated coronary artery bypass surgery were collected with the assistance of the hospital’s electronic records system. The follow-up duration was 12 months. Statistically significant P value cut-off taken as 0.05. Results: The mean age was 61.5 and 26.6% (n= 40) of the patients were female. Preoperative atrial fibrillation (Afib) prevalence was 13.3% (n= 20). No significant differences were observed in patient demographics, metabolic, systemic, and cardiovascular conditions between the group with preoperative atrial fibrillation and the control group (p> 0.05). However, the previous myocardial infarction rate was found higher (38.9 vs. 70.0, p= 0.009), and carotid artery stenosis disease prevalence was found lower (18.2 vs. 0.0, p= 0.038), also mean glomerular filtration rate (GFR) was found lower (85.9 vs. 69.7, p= 0.002) in the patients with Afib. Intraoperative parameters were not statistically different among the group (p> 0.05). Despite the preoperative dysthymia history, myocardial infarction prevalence, and poor kidney function; there was no difference in terms of postoperative acute kidney injury rates, stroke rates, perioperative complication rates, and thirty-day and 12-month survival (p> 0.05). However, the re-revascularization requirement was higher in patients in the Afib group. Conclusion: Atrial fibrillation is a prevalent comorbidity in coronary artery bypass grafting patients. However, it was not found as a factor that related to mortality or morbidity and coronary surgery seems feasible in this patient group.
- Open Access
- 30 April 2023
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 6 (1) , 169-177
Sistemik Otoimmün Hastalık Tanılı Hastalarda Koroner Arter Bypass Greftleme Cerrahisi
Introduction: Systemic autoimmune diseases are risk factors for cardiovascular diseases and have also been identified as a factor that worsens perioperative outcomes in various surgical specialities. This study investigated the effects of systemic autoimmune diseases on coronary surgery outcomes. Methods: One hundred fifty-one patients were included in this study. hundred-forty-four patients without autoimmune disease were in the second group and seven patients with systemic autoimmune disease who underwent isolated coronary surgery were in the second group. Hospital Electronic recording systems were used for data collection. The follow-up period is 12 months. A statistically significant P value was taken as 0.05. Results: The two groups were comparable preoperatively, only the prevalence of hypertension and diabetes was significantly higher in the second group. There was no significant difference between the two groups in terms of intraoperative variables. Perioperative complications (excluding stroke), 30-day mortality and post-operative cardiopulmonary resuscitation rate were significantly higher in the second group, however there was no difference between the two groups in terms of 12-month survival. Conclusion: Despite systemic autoimmune diseases being found a factor that increases complications in terms of coronary surgery, coronary surgery is promising with its success in 12-month survival and repeated revascularization rate in these patients.
- 30 April 2023
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 6 (1) , 169-177
Open AccessSistemik Otoimmün Hastalık Tanılı Hastalarda Koroner Arter Bypass Greftleme Cerrahisi
Introduction: Systemic autoimmune diseases are risk factors for cardiovascular diseases and have also been identified as a factor that worsens perioperative outcomes in various surgical specialities. This study investigated the effects of systemic autoimmune diseases on coronary surgery outcomes. Methods: One hundred fifty-one patients were included in this study. hundred-forty-four patients without autoimmune disease were in the second group and seven patients with systemic autoimmune disease who underwent isolated coronary surgery were in the second group. Hospital Electronic recording systems were used for data collection. The follow-up period is 12 months. A statistically significant P value was taken as 0.05. Results: The two groups were comparable preoperatively, only the prevalence of hypertension and diabetes was significantly higher in the second group. There was no significant difference between the two groups in terms of intraoperative variables. Perioperative complications (excluding stroke), 30-day mortality and post-operative cardiopulmonary resuscitation rate were significantly higher in the second group, however there was no difference between the two groups in terms of 12-month survival. Conclusion: Despite systemic autoimmune diseases being found a factor that increases complications in terms of coronary surgery, coronary surgery is promising with its success in 12-month survival and repeated revascularization rate in these patients.
- Open Access
- 22 October 2020
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 3 (4) , 460-465
Sol ventrikül fonksiyonları bozulmuş, ejeksiyon fraksiyonu %40’ın altında olan, koroner arter by-pass greft operasyonu yapılacak hastalara verilen levosimendan tedavisinin, kardiyoprotektif etkinliğinin postoperatif olarak değerlendirilmesi
En tr ABSTRACT Aim: The purpose of this study is to demonstrate the postoperative cardioprotective efficacy of preoperative levosimendan treatment in patients with impaired left ventricular function undergoing coronary by-pass surgery. Materyal and Method: This study was performed prospectively between November 2008 and September 2009 in Eskişehir Osmangazi Univercity Department of Cardiovascular Surgery. Twenty patients with coronary artery disease (CAD) between the ages of 48-78 and ejection fraction (EF) below 40% were included in the study. levosimendan was given to the first group preoperatively(experimental group). Group 2 was the control group. Coronary artery bypass graft (CABG) surgery was performed in all of them. One group received additional levosimendan infusion, preoperatively. Age, comorbidity, cardiopulmonary by-pass (CPB) time, cross clamp (CC) time, patient vessel number, anastomosis number, extubation times, intensive care stay and hospital stay were recorded. Preoperative, postoperative 1st day and postoperative 7th day nt-proBNP values and preoperative and postoperative 15th day ejection fraction (EF) values with echocardiography (ECHO) were measured. The cardioprotective efficacy of the drug was evaluated by comparing the data of the control group and the experimental group. Results: No statistically significant difference was found between the two groups in terms of CPB time, CC time, age, comorbidity, number of sick vessels, number of anastomosis, extubation time, length of stay in intensive care and hospital stay. (P> 0.05). There was no significant difference between the groups in preoperative EF values (P> 0.05). The mean values of EF measurements on the postoperative 15th day were calculated as 39% in the experimental group and 40% in the control group. The increase in EF values was greater in the experimental group. This increase was found to be more significant in the experimental group (P = 0.008). There was a significant difference between the groups in preoperative and postoperative 1st day n-tproBNP values (P 0,05). Preoperatif ölçülen EF değerlerinde gruplar arasında anlamlı farklılık gözlenmedi (P>0,05). Postoperatif 15. gündeki EF ölçümlerinin ortalama değerleri deney grubunda %39, kontrol grubunda %40 olarak hesaplandı. EF değerlerindeki artış deney grubunda daha fazlaydı. Bu artışın deney grubunda daha anlamlı olduğu tespit edildi (P=0,008). Gruplar arasında preoperatif ve postoperatif 1. gün bakılan nt-proBNP değerleri arasında anlamlı farklılık vardı (P<0,05). Gruplarda nt-proBNP değerlerinde postoperatif 7. güne kadar anlamlı bir artış gözlendi. (P0,05). Sonuç: Bu çalışma sonucunda KABG cerrahisinde düşük EF’li hastalarda levosimendaın myokardiyal koruma ve kontraktilite üzerine olumlu etkinliği olduğu saptandı.
- 22 October 2020
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 3 (4) , 460-465
Open AccessSol ventrikül fonksiyonları bozulmuş, ejeksiyon fraksiyonu %40’ın altında olan, koroner arter by-pass greft operasyonu yapılacak hastalara verilen levosimendan tedavisinin, kardiyoprotektif etkinliğinin postoperatif olarak değerlendirilmesi
En tr ABSTRACT Aim: The purpose of this study is to demonstrate the postoperative cardioprotective efficacy of preoperative levosimendan treatment in patients with impaired left ventricular function undergoing coronary by-pass surgery. Materyal and Method: This study was performed prospectively between November 2008 and September 2009 in Eskişehir Osmangazi Univercity Department of Cardiovascular Surgery. Twenty patients with coronary artery disease (CAD) between the ages of 48-78 and ejection fraction (EF) below 40% were included in the study. levosimendan was given to the first group preoperatively(experimental group). Group 2 was the control group. Coronary artery bypass graft (CABG) surgery was performed in all of them. One group received additional levosimendan infusion, preoperatively. Age, comorbidity, cardiopulmonary by-pass (CPB) time, cross clamp (CC) time, patient vessel number, anastomosis number, extubation times, intensive care stay and hospital stay were recorded. Preoperative, postoperative 1st day and postoperative 7th day nt-proBNP values and preoperative and postoperative 15th day ejection fraction (EF) values with echocardiography (ECHO) were measured. The cardioprotective efficacy of the drug was evaluated by comparing the data of the control group and the experimental group. Results: No statistically significant difference was found between the two groups in terms of CPB time, CC time, age, comorbidity, number of sick vessels, number of anastomosis, extubation time, length of stay in intensive care and hospital stay. (P> 0.05). There was no significant difference between the groups in preoperative EF values (P> 0.05). The mean values of EF measurements on the postoperative 15th day were calculated as 39% in the experimental group and 40% in the control group. The increase in EF values was greater in the experimental group. This increase was found to be more significant in the experimental group (P = 0.008). There was a significant difference between the groups in preoperative and postoperative 1st day n-tproBNP values (P 0,05). Preoperatif ölçülen EF değerlerinde gruplar arasında anlamlı farklılık gözlenmedi (P>0,05). Postoperatif 15. gündeki EF ölçümlerinin ortalama değerleri deney grubunda %39, kontrol grubunda %40 olarak hesaplandı. EF değerlerindeki artış deney grubunda daha fazlaydı. Bu artışın deney grubunda daha anlamlı olduğu tespit edildi (P=0,008). Gruplar arasında preoperatif ve postoperatif 1. gün bakılan nt-proBNP değerleri arasında anlamlı farklılık vardı (P<0,05). Gruplarda nt-proBNP değerlerinde postoperatif 7. güne kadar anlamlı bir artış gözlendi. (P0,05). Sonuç: Bu çalışma sonucunda KABG cerrahisinde düşük EF’li hastalarda levosimendaın myokardiyal koruma ve kontraktilite üzerine olumlu etkinliği olduğu saptandı.